We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
Cap. Flow
+$3.51M
Cap. Flow %
1.61%
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$934K
2
MASI
Masimo
MASI
+$931K
3
PDYN icon
Palladyne AI
PDYN
+$929K
4
ELS icon
Equity Lifestyle Properties
ELS
+$926K
5
BWA icon
BorgWarner
BWA
+$898K

Top Sells

Rank Stock Value
1
CG icon
Carlyle Group
CG
+$962K
2
WGS icon
GeneDx Holdings
WGS
+$933K
3
VSAT icon
Viasat
VSAT
+$852K
4
INFA
Informatica
INFA
+$807K
5
AMGN icon
Amgen
AMGN
+$804K

Sector Composition

Rank Sector Weight
1 Healthcare 17.61%
2 Technology 17.16%
3 Industrials 15.49%
4 Financials 11.59%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
176
FedEx
FDX
$74.5B
$413K 0.19%
+1,693
New +$439K
SHEL icon
177
Shell
SHEL
$245B
$412K 0.19%
+5,627
New +$379K
SHCO
178
DELISTED
Soho House & Co
SHCO
$412K 0.19%
66,706
+55,783
+511% +$403K
EFX icon
179
Equifax
EFX
$20.3B
$412K 0.19%
1,692
-10
-0.6% -$2.51K
ABEV icon
180
Ambev
ABEV
$47.3B
$410K 0.19%
175,977
+26,023
+17% +$52.1K
CSTL icon
181
Castle Biosciences
CSTL
$749M
$409K 0.19%
20,432
-8,712
-30% -$216K
SRPT icon
182
Sarepta Therapeutics
SRPT
$1.66B
$409K 0.19%
+6,409
New +$675K
SUPN icon
183
Supernus Pharmaceuticals
SUPN
$2.68B
$406K 0.19%
+12,412
New +$440K
WRB icon
184
W.R. Berkley
WRB
$28B
$405K 0.19%
5,696
+1,775
+45% +$109K
GRND icon
185
Grindr
GRND
$2.64B
$405K 0.19%
+22,601
New +$397K
BGS icon
186
B&G Foods
BGS
$285M
$402K 0.18%
+58,460
New +$390K
AXGN icon
187
Axogen
AXGN
$2.1B
$401K 0.18%
+21,683
New +$391K
DXC icon
188
DXC Technology
DXC
$1.63B
$399K 0.18%
23,430
-8,440
-26% -$164K
RARE icon
189
Ultragenyx Pharmaceutical
RARE
$2.65B
$398K 0.18%
10,982
+4,043
+58% +$168K
AMAT icon
190
Applied Materials
AMAT
$426B
$395K 0.18%
2,725
+533
+24% +$89.6K
WRBY icon
191
Warby Parker
WRBY
$3.01B
$395K 0.18%
+21,649
New +$517K
RGA icon
192
Reinsurance Group of America
RGA
$15.7B
$394K 0.18%
1,999
+891
+80% +$185K
CALY
193
Callaway Golf Company
CALY
$3.26B
$394K 0.18%
+59,724
New +$438K
TNET icon
194
TriNet
TNET
$2.84B
$393K 0.18%
+4,964
New +$412K
KWR icon
195
Quaker Houghton
KWR
$2.63B
$392K 0.18%
3,168
-662
-17% -$89.8K
ADBE icon
196
Adobe
ADBE
$89.5B
$387K 0.18%
1,009
-76
-7% -$32.6K
PPG icon
197
PPG Industries
PPG
$25.9B
$386K 0.18%
3,531
+430
+14% +$49.6K
WAB icon
198
Wabtec
WAB
$51.1B
$385K 0.18%
+2,125
New +$407K
RSI icon
199
Rush Street Interactive
RSI
$3.24B
$384K 0.18%
+35,809
New +$471K
LYFT icon
200
Lyft
LYFT
$5.39B
$381K 0.17%
+32,129
New +$418K
6 7
8
9 10

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q1 2025 Portfolio in Review

As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
  • EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
  • EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
  • EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
  • EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
  • EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
  • EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.

Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.